(LYINC) Lyxor MSCI India Acc EUR - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Etf • ISIN: FR0010361683 • India Equity
LYINC: Equities, Indian, Stocks, Shares
The Lyxor MSCI India UCITS ETF Acc EUR CHF (Ticker: LYINC) is a UCITS-compliant exchange-traded fund designed to provide investors with exposure to the Indian equity market. Listed on the SIX Swiss Exchange (SWX), the fund is structured to track the performance of the Morningstar India Total Return USD Index, which is a broad market index comprising a diverse range of Indian companies across various sectors. The fund is denominated in Swiss Francs (CHF) and distributes income in EUR, making it accessible to European investors seeking diversification into one of Asias fastest-growing economies.
As of the latest available data, the funds assets under management (AUM) stand at approximately 921.85 million CHF, reflecting its popularity among investors seeking exposure to Indias growth story. The funds structure allows it to capture the performance of its underlying index, which includes large-cap, mid cap, and small-cap Indian equities, thereby providing a comprehensive representation of the Indian stock market. The Morningstar India Total Return USD Index is designed to measure the total return of Indian equities in USD terms, including dividends and other distributions. This index is widely followed by investors and is considered a benchmark for Indian equity performance.
Looking ahead, the future outlook for the Lyxor MSCI India UCITS ETF Acc EUR CHF will likely be influenced by several key factors. Indias economic growth trajectory, driven by its young population, digital transformation, and structural reforms, is expected to remain robust. The Indian equity market has shown resilience in the face of global macroeconomic challenges, and its long-term growth prospects are underpinned by increasing urbanization, urbanization, and consumer spending. However, as with any emerging market, risks such as currency volatility, regulatory changes, and geopolitical uncertainties could impact the funds performance. From a valuation perspective, the Indian market has often traded at a premium to other emerging markets, which could lead to periods of consolidation in the near term. Nevertheless, the funds diversified exposure to Indias growth sectors, including technology, financials, and consumer goods, positions it well to capitalize on the countrys long-term growth potential.
Additional Sources for LYINC ETF
LYINC ETF Overview
Market Cap in USD | 1,016m |
Category | India Equity |
TER | 0.85% |
IPO / Inception | 2006-11-07 |
LYINC ETF Ratings
Growth 5y | 54.1% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -10.5 |
Analysts | - |
Fair Price Momentum | 23.48 CHF |
Fair Price DCF | - |
LYINC Dividends
No Dividends PaidLYINC Growth Ratios
Growth Correlation 3m | -96.5% |
Growth Correlation 12m | -22.5% |
Growth Correlation 5y | 79.3% |
CAGR 5y | 13.58% |
CAGR/Max DD 5y | 0.64 |
Sharpe Ratio 12m | 0.46 |
Alpha | -13.18 |
Beta | 0.44 |
Volatility | 15.41% |
Current Volume | 0k |
Average Volume 20d | 2.1k |
As of March 14, 2025, the stock is trading at CHF 25.50 with a total of 42 shares traded.
Over the past week, the price has changed by -1.33%, over one month by -6.28%, over three months by -15.77% and over the past year by -5.49%.
Partly, yes. Based on ValueRay Analyses, Lyxor MSCI India Acc EUR (SW:LYINC) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 54.10 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LYINC as of March 2025 is 23.48. This means that LYINC is currently overvalued and has a potential downside of -7.92%.
Lyxor MSCI India Acc EUR has no consensus analysts rating.
According to ValueRays Forecast Model, LYINC Lyxor MSCI India Acc EUR will be worth about 25.8 in March 2026. The stock is currently trading at 25.50. This means that the stock has a potential upside of +1.1%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.8 | 1.1% |